rs2230896

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_000302.4(PLOD1):​c.1141G>A​(p.Val381Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0012 in 1,605,070 control chromosomes in the GnomAD database, including 12 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. V381L) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.0063 ( 9 hom., cov: 31)
Exomes 𝑓: 0.00067 ( 3 hom. )

Consequence

PLOD1
NM_000302.4 missense

Scores

17

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:10

Conservation

PhyloP100: -0.202

Publications

2 publications found
Variant links:
Genes affected
PLOD1 (HGNC:9081): (procollagen-lysine,2-oxoglutarate 5-dioxygenase 1) Lysyl hydroxylase is a membrane-bound homodimeric protein localized to the cisternae of the endoplasmic reticulum. The enzyme (cofactors iron and ascorbate) catalyzes the hydroxylation of lysyl residues in collagen-like peptides. The resultant hydroxylysyl groups are attachment sites for carbohydrates in collagen and thus are critical for the stability of intermolecular crosslinks. Some patients with Ehlers-Danlos syndrome type VI have deficiencies in lysyl hydroxylase activity. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Oct 2015]
PLOD1 Gene-Disease associations (from GenCC):
  • Ehlers-Danlos syndrome, kyphoscoliotic type 1
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp, Orphanet, PanelApp Australia, G2P

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.011404276).
BP6
Variant 1-11963575-G-A is Benign according to our data. Variant chr1-11963575-G-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 263885.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00626 (953/152280) while in subpopulation AFR AF = 0.0217 (901/41548). AF 95% confidence interval is 0.0205. There are 9 homozygotes in GnomAd4. There are 453 alleles in the male GnomAd4 subpopulation. Median coverage is 31. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 9 AR gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000302.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PLOD1
NM_000302.4
MANE Select
c.1141G>Ap.Val381Met
missense
Exon 11 of 19NP_000293.2
PLOD1
NM_001316320.2
c.1282G>Ap.Val428Met
missense
Exon 12 of 20NP_001303249.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PLOD1
ENST00000196061.5
TSL:1 MANE Select
c.1141G>Ap.Val381Met
missense
Exon 11 of 19ENSP00000196061.4

Frequencies

GnomAD3 genomes
AF:
0.00624
AC:
950
AN:
152162
Hom.:
9
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.0217
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00256
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000882
Gnomad OTH
AF:
0.00383
GnomAD2 exomes
AF:
0.00169
AC:
395
AN:
234296
AF XY:
0.00112
show subpopulations
Gnomad AFR exome
AF:
0.0232
Gnomad AMR exome
AF:
0.00108
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000113
Gnomad OTH exome
AF:
0.000524
GnomAD4 exome
AF:
0.000670
AC:
973
AN:
1452790
Hom.:
3
Cov.:
31
AF XY:
0.000538
AC XY:
388
AN XY:
721690
show subpopulations
African (AFR)
AF:
0.0221
AC:
738
AN:
33438
American (AMR)
AF:
0.00107
AC:
46
AN:
43104
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25840
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39386
South Asian (SAS)
AF:
0.0000238
AC:
2
AN:
84156
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
52542
Middle Eastern (MID)
AF:
0.00104
AC:
6
AN:
5756
European-Non Finnish (NFE)
AF:
0.0000992
AC:
110
AN:
1108510
Other (OTH)
AF:
0.00118
AC:
71
AN:
60058
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
58
116
174
232
290
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
24
48
72
96
120
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00626
AC:
953
AN:
152280
Hom.:
9
Cov.:
31
AF XY:
0.00608
AC XY:
453
AN XY:
74454
show subpopulations
African (AFR)
AF:
0.0217
AC:
901
AN:
41548
American (AMR)
AF:
0.00249
AC:
38
AN:
15284
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5192
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4828
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10620
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0000882
AC:
6
AN:
68020
Other (OTH)
AF:
0.00379
AC:
8
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
43
86
129
172
215
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00230
Hom.:
6
Bravo
AF:
0.00739
ESP6500AA
AF:
0.0241
AC:
106
ESP6500EA
AF:
0.000116
AC:
1
ExAC
AF:
0.00195
AC:
237
Asia WGS
AF:
0.00144
AC:
5
AN:
3478

ClinVar

ClinVar submissions as Germline

Significance:Benign/Likely benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
3
Ehlers-Danlos syndrome, kyphoscoliotic type 1 (3)
-
-
3
not specified (3)
-
-
2
not provided (2)
-
-
1
Ehlers-Danlos syndrome (1)
-
-
1
Familial thoracic aortic aneurysm and aortic dissection (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.087
BayesDel_addAF
Benign
-0.50
T
BayesDel_noAF
Benign
-0.47
CADD
Benign
10
DANN
Benign
0.94
DEOGEN2
Benign
0.13
T
Eigen
Benign
-1.2
Eigen_PC
Benign
-1.2
FATHMM_MKL
Benign
0.15
N
LIST_S2
Benign
0.83
T
MetaRNN
Benign
0.011
T
MetaSVM
Benign
-0.88
T
MutationAssessor
Benign
0.94
L
PhyloP100
-0.20
PrimateAI
Benign
0.32
T
PROVEAN
Benign
-1.6
N
REVEL
Benign
0.17
Sift
Benign
0.17
T
Sift4G
Benign
0.15
T
Polyphen
0.0020
B
Vest4
0.45
MVP
0.53
MPC
0.21
ClinPred
0.0035
T
GERP RS
-4.7
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.038
gMVP
0.57
Mutation Taster
=98/2
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2230896; hg19: chr1-12023632; API